Doctoral thesis at Oslo University Hospital based on clinical studies carried out in collaboration with Bionor Pharma

Oslo, 07.12.2016. Cand. Med. Kristin Brekke will defend her doctoral thesis entitled “Therapeutic vaccination in chronic HIV infection – clinical studies” on Thursday 8th December at Oslo University Hospital. Link to more information (in Norwegian). http://www.med.uio.no/klinmed/forskning/aktuelt/arrangementer/disputaser/2016/brekke-kristin.html Her thesis describes analyses from three clinical trials that have been carried out at Oslo University Hospital (Ullevål) in …

Read more

Poster presentation at NIH “Strategies for an HIV Cure” meeting in Bethesda, Maryland US

Bionor Pharma ASA has been selected to present a poster entitled “Approaching HIV Functional Cure Applying Vacc-4x, a peptide-based HIV Therapeutic Vaccine: Clinical Development Methodological Considerations” at the National Institute of Health (NIH) “Strategies for an HIV Cure” meeting from 14th-16th November 2016, in Bethesda, Maryland, USA. Bionor At NIH 2016 The poster compiles data …

Read more

Poster presentation at the 18th Institute of Human Virology Annual Conference

Preliminary data from a Bionor research project supported by the Research Council of Norway GLOBVAC program will be presented as a poster today at the 18th Annual International Meeting of the Institute of Human Virology which takes places from 19-22 September in Baltimore, Maryland USA (http://medschool.umaryland.edu/ihvmeeting/default.html). The poster will be presented by Dr. Pete Smith, …

Read more